Baker Bros. Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Baker Bros. Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,180	Closed	-$862K	–	123
2021 Q1	$862K	Hold	11,180	–	–	﹤0.01%	120
2020 Q4	$1.11M	Sell	11,180 -1,232	-10%	-$151K	﹤0.01%	116
2020 Q3	$1.76M	Sell	12,412 -660	-5%	-$110K	0.01%	104
2020 Q2	$2.58M	Hold	13,072	–	–	0.01%	94
2020 Q1	$2.56M	Hold	13,072	–	–	0.02%	84
2019 Q4	$2.7M	Sell	13,072 -12,000	-48%	-$2.22M	0.01%	83
2019 Q3	$3.83M	Hold	25,072	–	–	0.03%	70
2019 Q2	$3.23M	Hold	25,072	–	–	0.02%	72
2019 Q1	$2.95M	Hold	25,072	–	–	0.02%	72
2018 Q4	$2.3M	Sell	25,072 -212,119	-89%	-$21.5M	0.02%	70
2018 Q3	$26.7M	Sell	237,191 -22,703	-9%	-$2.4M	0.18%	35
2018 Q2	$24M	Hold	259,894	–	–	0.18%	37
2018 Q1	$25.9M	Hold	259,894	–	–	0.22%	38
2017 Q4	$24.4M	Hold	259,894	–	–	0.21%	40
2017 Q3	$26.4M	Hold	259,894	–	–	0.21%	31
2017 Q2	$19.9M	Hold	259,894	–	–	0.17%	31
2017 Q1	$22.4M	Hold	259,894	–	–	0.18%	33
2016 Q4	$16.7M	Hold	259,894	–	–	0.16%	37
2016 Q3	$16.8M	Hold	259,894	–	–	0.15%	41
2016 Q2	$14.4M	Sell	259,894 -43,500	-14%	-$2.19M	0.15%	44
2016 Q1	$12.7M	Sell	303,394 -65,882	-18%	-$3.06M	0.13%	48
2015 Q4	$23.2M	Hold	369,276	–	–	0.19%	38
2015 Q3	$15M	Hold	369,276	–	–	0.14%	50
2015 Q2	$19M	Buy	+369,276	New	+$19.6M	0.17%	48

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Baker Bros. Advisors's LKFT Position: Q2 2021 in Review

Baker Bros. Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 11,180 shares — an estimated $862K sold.

Baker Bros. Advisors first reported a position in LKFT in Q2 2015 and held it in 24 quarters. The position peaked at $26.7M in Q3 2018. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

Baker Bros. Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Baker Bros. Advisors sold 11,180 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $862K.
Baker Bros. Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 24 quarters.
Baker Bros. Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $26.7M in Q3 2018.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Baker Bros. Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.